132 related articles for article (PubMed ID: 24613474)
1. Influence of cognitive impairment on the management of ischaemic stroke.
Murao K; Bombois S; Cordonnier C; Hénon H; Bordet R; Pasquier F; Leys D
Rev Neurol (Paris); 2014 Mar; 170(3):177-86. PubMed ID: 24613474
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment.
Murao K; Leys D; Jacquin A; Kitazono T; Bordet R; Béjot Y; Kimura K; Godefroy O; Wakisaka Y; Moulin S; Ago T; Sibon I; Bombois S; Mas JL; Hénon H; Pasquier F; Giroud M; Cordonnier C; Okada Y;
Neurology; 2014 Jun; 82(23):2048-54. PubMed ID: 24827495
[TBL] [Abstract][Full Text] [Related]
4. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
Calvet D; Bracard S; Mas JL;
Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
[TBL] [Abstract][Full Text] [Related]
6. Acute ischemic stroke treatment in 2007.
Goldstein LB
Circulation; 2007 Sep; 116(13):1504-14. PubMed ID: 17893286
[No Abstract] [Full Text] [Related]
7. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
Eissa A; Krass I; Bajorek BV
J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
[TBL] [Abstract][Full Text] [Related]
8. Drug treatments in the secondary prevention of ischaemic stroke.
Schulz UG
Maturitas; 2013 Nov; 76(3):267-71. PubMed ID: 23769546
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.
Rothwell PM; Algra A; Amarenco P
Lancet; 2011 May; 377(9778):1681-92. PubMed ID: 21571151
[TBL] [Abstract][Full Text] [Related]
10. How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials.
Gorelick PB
Ann N Y Acad Sci; 2012 Sep; 1268():85-94. PubMed ID: 22994226
[TBL] [Abstract][Full Text] [Related]
11. Advances and challenges in treatment and prevention of ischemic stroke.
Grossman AW; Broderick JP
Ann Neurol; 2013 Sep; 74(3):363-72. PubMed ID: 23929628
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the European and Japanese guidelines for the management of ischemic stroke.
Kern R; Nagayama M; Toyoda K; Steiner T; Hennerici MG; Shinohara Y
Cerebrovasc Dis; 2013; 35(5):402-18. PubMed ID: 23712178
[TBL] [Abstract][Full Text] [Related]
13. Should more patients with acute ischaemic stroke receive thrombolytic treatment?
Wardlaw JM; Sandercock PA; Murray V
BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748
[No Abstract] [Full Text] [Related]
14. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
15. The management of stroke patients by neurologists: common questions and new observations.
Lopez-Yunez AM
Semin Neurol; 2002 Mar; 22(1):53-61. PubMed ID: 12170393
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing haemorrhagic transformation in ischaemic stroke.
Álvarez-Sabín J; Maisterra O; Santamarina E; Kase CS
Lancet Neurol; 2013 Jul; 12(7):689-705. PubMed ID: 23726850
[TBL] [Abstract][Full Text] [Related]
17. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
[TBL] [Abstract][Full Text] [Related]
18. Effects of Early Hypertension Control after Ischaemic Stroke on the Outcome: A Meta-Analysis.
Liu S; Li C; Li T; Xiong J; Zhao X
Cerebrovasc Dis; 2015; 40(5-6):270-8. PubMed ID: 26488895
[TBL] [Abstract][Full Text] [Related]
19. [Hypertension and dementia].
Hanon O
Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):204-8. PubMed ID: 24970721
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
